These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Chimerism and minimal residual disease monitoring after reduced intensity conditioning (RIC) allogeneic transplantation. Pérez-Simón JA; Caballero D; Diez-Campelo M; Lopez-Pérez R; Mateos G; Cañizo C; Vazquez L; Vidriales B; Mateos MV; Gonzalez M; San Miguel JF Leukemia; 2002 Aug; 16(8):1423-31. PubMed ID: 12145680 [TBL] [Abstract][Full Text] [Related]
24. High-dose therapy with autologous or allogeneic transplantation as salvage therapy for small cleaved cell lymphoma of follicular center cell origin. Stein RS; Greer JP; Goodman S; Kallianpur A; Ahmed MS; Wolff SN Bone Marrow Transplant; 1999 Feb; 23(3):227-33. PubMed ID: 10084253 [TBL] [Abstract][Full Text] [Related]
25. Pediatric liver transplantation for Langerhans' cell histiocytosis. Zandi P; Panis Y; Debray D; Bernard O; Houssin D Hepatology; 1995 Jan; 21(1):129-33. PubMed ID: 7806145 [TBL] [Abstract][Full Text] [Related]
26. Autotransplants for Hodgkin's disease in first relapse or second remission: a report from the autologous blood and marrow transplant registry (ABMTR). Lazarus HM; Loberiza FR; Zhang MJ; Armitage JO; Ballen KK; Bashey A; Bolwell BJ; Burns LJ; Freytes CO; Gale RP; Gibson J; Herzig RH; LeMaistre CF; Marks D; Mason J; Miller AM; Milone GA; Pavlovsky S; Reece DE; Rizzo JD; van Besien K; Vose JM; Horowitz MM Bone Marrow Transplant; 2001 Feb; 27(4):387-96. PubMed ID: 11313668 [TBL] [Abstract][Full Text] [Related]
27. Autologous bone marrow transplantation for progressive non-Hodgkin's lymphoma: clinical impact of immunophenotype and in vitro purging. Weisdorf DJ; Haake R; Miller WJ; McGlave PB; LeBien TW; Vallera DA; Lasky LC; Kim TH; Peterson BA; Ramsay NK Bone Marrow Transplant; 1991 Aug; 8(2):135-42. PubMed ID: 1933055 [TBL] [Abstract][Full Text] [Related]
28. Relapsed acute lymphoblastic leukemia: similar outcomes for autologous and allogeneic marrow transplantation in selected children. Parsons SK; Castellino SM; Lehmann LE; Eickhoff CE; Tarbell NJ; Sallan SE; Weinstein HJ; Billett AL Bone Marrow Transplant; 1996 May; 17(5):763-8. PubMed ID: 8733695 [TBL] [Abstract][Full Text] [Related]
29. Outcomes of autologous and allogeneic blood or marrow transplantation for mantle cell lymphoma. Kasamon YL; Jones RJ; Diehl LF; Nayer H; Borowitz MJ; Garrett-Mayer E; Ambinder RF; Abrams RA; Zhang Z; Flinn IW Biol Blood Marrow Transplant; 2005 Jan; 11(1):39-46. PubMed ID: 15625543 [TBL] [Abstract][Full Text] [Related]
30. Allogeneic bone marrow transplantation for children with histiocytic disorders: use of TBI and omission of etoposide in the conditioning regimen. Hale GA; Bowman LC; Woodard JP; Cunningham JM; Benaim E; Horwitz EM; Heslop HE; Krance RA; Leung W; Shearer PD; Handgretinger R Bone Marrow Transplant; 2003 Jun; 31(11):981-6. PubMed ID: 12774048 [TBL] [Abstract][Full Text] [Related]
31. Etoposide, cyclophosphamide and fractionated total body irradiation as a preparative regimen for marrow transplantation in patients with advanced hematological malignancies: a phase I study. Petersen FB; Buckner CD; Appelbaum FR; Sanders JE; Bensinger WI; Storb R; Deeg HJ; Witherspoon RP; Sullivan KM; Clift RA Bone Marrow Transplant; 1992 Jul; 10(1):83-8. PubMed ID: 1515884 [TBL] [Abstract][Full Text] [Related]
32. Long-term results in non randomized patients with acute myelogenous leukemia: a single institution experience. Deliliers GL; Annaloro C; Oriani A; Della Volpe A; Boschetti C; Cortelezzi A; Maiolo AT Ann Ital Med Int; 1998; 13(3):146-51. PubMed ID: 9859570 [TBL] [Abstract][Full Text] [Related]
33. Intensified conditioning regimen in bone marrow transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia. Kröger N; Krüger W; Wacker-Backhaus G; Hegewisch-Becker S; Stockschläder M; Fuchs N; Rüssmann B; Renges H; Dürken M; Bielack S; de Wit M; Schuch G; Bartels H; Braumann D; Kuse R; Kabisch H; Erttmann R; Zander AR Bone Marrow Transplant; 1998 Dec; 22(11):1029-33. PubMed ID: 9877263 [TBL] [Abstract][Full Text] [Related]
34. A study of thiotepa, etoposide and fractionated total body irradiation as a preparative regimen prior to bone marrow transplantation for poor prognosis patients with neuroblastoma. Kamani N; August CS; Bunin N; Leahey A; Bayever E; Goldwein J; Zusman J; Evans AE; Angio GD Bone Marrow Transplant; 1996 Jun; 17(6):911-6. PubMed ID: 8807093 [TBL] [Abstract][Full Text] [Related]
35. Bone marrow transplantation in 63 adult patients with acute lymphoblastic leukemia in first complete remission. Vey N; Blaise D; Stoppa AM; Bouabdallah R; Lafage M; Sainty D; Cowen D; Viens P; Lepeu G; Blanc AP Bone Marrow Transplant; 1994 Sep; 14(3):383-8. PubMed ID: 7994259 [TBL] [Abstract][Full Text] [Related]
36. Conventional hematopoietic stem cell transplants from identical or alternative donors are feasible in recipients relapsing after an autograft. di Grazia C; Raiola AM; Van Lint MT; Lamparelli T; Gualandi F; Berisso G; Bregante S; Dominietto A; Mordini N; Bruno B; Frassoni F; Bacigalupo A Haematologica; 2001 Jun; 86(6):646-51. PubMed ID: 11418375 [TBL] [Abstract][Full Text] [Related]
37. [Langerhans cell histiocytosis in adult patients--a disease with many faces. Experience of a centre and an overview of the disease symptoms]. Adam Z; Pour L; Krejcí M; Neubauer J; Vanícek J; Vasků V; Hájek R Vnitr Lek; 2008 Nov; 54(11):1063-80. PubMed ID: 19069680 [TBL] [Abstract][Full Text] [Related]
38. Treatment of patients with myelodysplastic syndromes with allogeneic bone marrow transplantation from genotypically HLA-identical sibling and alternative donors. Demuynck H; Verhoef GE; Zachee P; Emonds MP; van der Schueren E; van den Berghe H; Vandenberghe P; Casteels-Van Daele M; Boogaerts MA Bone Marrow Transplant; 1996 May; 17(5):745-51. PubMed ID: 8733692 [TBL] [Abstract][Full Text] [Related]